MolPros - Translational Cancer Research
Molecular Prediction of Prostate Cancer Risk and Aggressiveness (MolPros) is an inter-disciplinary translational cancer research alliance bringing together experts from Denmark, Germany, China and USA.
The research alliance has been established to develop new molecular tools to:
- identify men with high risk of prostate cancer
- to distinguish aggressive from non-aggressive prostate cancer
MolPros was a 4-year project (2011-2014; extended to July 2015) supported by a grant (~2 mil. Euros, 14.5 mil. DKK) from the Danish Council for Strategic Research and co-financed (~1 mil. Euros, 7 mil. DKK) by the involved partners.
The genetic risk test developed in MolPros is used in two studies ProCaRis (2013-2014) and ProCaRis II (2016-2018).